If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Education
Download FREE Excerpt
6 Info Graphics
8 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Forward-thinking pharma companies have realized that funding the post-graduate education of new investigators is a way to potentially advance understanding in therapeutic areas that are key to the company’s success. However, US fellowship grant practices among pharma companies differ; some have a dedicated fellowship program while others award them ad hoc, for instance. Funding levels for fellowships also vary.
Best Practices, LLC conducted this short study to gather insights on current practices around the funding and administration of pharma fellowship programs that provide grants supporting post-graduate medical education in the United States.
"Best Practices in Funding US Fellowships: Using Pharma Grants Effectively to Support Post-Graduate Education" will allow you to see how your company’s approach compares with industry peers on the evolving use of fellowships to support new areas of research.
Questions addressed in the short study include:
Best Practices, LLC engaged 10 Medical Affairs/grants leaders from 10 pharma companies through a benchmarking survey. All responses were US-focused.
Health Care; Pharmaceutical; Biotech; Manufacturing
Eisai; Verastem Oncology; Allergan; Astellas; EMD Serono; Sanofi Genzyme; Mallinckrodt; Teva Pharmaceutical Industries Ltd; Lundbeck; Vifor Pharma